Steris | STE - Operating Expenses

Stock Price
214.57
Daily Change
2.22 1.05%
Monthly
-12.57%
Yearly
-5.32%
Q1 Forecast
208.09

Steris reported $1.22B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
3M USD 4.92B 10M Dec/2025
Accuray USD 37.18M 567K Dec/2024
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
CONMED USD 336.58M 10.53M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Ecolab USD 3.41B 30.8M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Fortive USD 897M 1.39B Dec/2025
Getinge SEK 9.99B 2.3B Dec/2024
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
Olympus JPY 233.04B 18.77B Dec/2025
Orthofix International USD 10.89M 209.57M Sep/2024
Owens Minor USD -429.51M 1.05B Sep/2025
ResMed USD 925.21M 51.98M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025